BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35014832)

  • 1. In Cellulo Crystallization of Human Neuraminidase 1 and Biological Roles of
    Tsukimoto J; Takeuchi Y; Horii Y; Iniwa T; Fukushi Y; Nishioka SI; Itoh K
    ACS Appl Bio Mater; 2022 Jan; 5(1):205-213. PubMed ID: 35014832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent.
    Itoh K; Tsukimoto J
    Glycoconj J; 2023 Dec; 40(6):611-619. PubMed ID: 38147151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1.
    Wang D; Zaitsev S; Taylor G; d'Azzo A; Bonten E
    Biochim Biophys Acta; 2009 Apr; 1790(4):275-82. PubMed ID: 19714866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Production and Isolation of Human Neuraminidase-1
    Koiwai K; Tsukimoto J; Higashi T; Mafuné F; Miyajima K; Nakane T; Matsugaki N; Kato R; Sirigu S; Jakobi A; Wilmanns M; Sugahara M; Tanaka T; Tono K; Joti Y; Yabashi M; Nureki O; Mizohata E; Nakatsu T; Nango E; Iwata S; Chavas LMG; Senda T; Itoh K; Yumoto F
    ACS Appl Bio Mater; 2019 Nov; 2(11):4941-4952. PubMed ID: 35021494
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysosomal localization of Japanese medaka (Oryzias latipes) Neu1 sialidase and its highly conserved enzymatic profiles with human.
    Ryuzono S; Takase R; Oishi K; Ikeda A; Chigwechokha PK; Funahashi A; Komatsu M; Miyagi T; Shiozaki K
    Gene; 2016 Jan; 575(2 Pt 2):513-523. PubMed ID: 26432003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
    Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
    Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sialidase NEU1 directly interacts with the juxtamembranous segment of the cytoplasmic domain of mucin-1 to inhibit downstream PI3K-Akt signaling.
    Hyun SW; Imamura A; Ishida H; Piepenbrink KH; Goldblum SE; Lillehoj EP
    J Biol Chem; 2021 Nov; 297(5):101337. PubMed ID: 34688655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of Neu1-knockout zebrafish and its abnormal clinical phenotypes.
    Okada K; Takase R; Hamaoka Y; Honda A; Ikeda A; Hokazono Y; Maeda Y; Hayasaka O; Kotani T; Komatsu M; Shiozaki K
    Biochem J; 2020 Aug; 477(15):2841-2857. PubMed ID: 32686823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in
    Karmakar J; Roy S; Mandal C
    Front Immunol; 2019; 10():2360. PubMed ID: 31649671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the immunoregulatory sialidase NEU1.
    Gorelik A; Illes K; Mazhab-Jafari MT; Nagar B
    Sci Adv; 2023 May; 9(20):eadf8169. PubMed ID: 37205763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization.
    Bonten EJ; Campos Y; Zaitsev V; Nourse A; Waddell B; Lewis W; Taylor G; d'Azzo A
    J Biol Chem; 2009 Oct; 284(41):28430-28441. PubMed ID: 19666471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neu1 deficiency increases the susceptibility of zebrafish to Edwardsiella piscicida infection via lysosomal dysfunction.
    Sahashi D; Kubo Y; Ishii M; Ikeda A; Yamasaki C; Komatsu M; Shiozaki K
    Gene; 2022 Aug; 836():146667. PubMed ID: 35714800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency].
    Guo YK; Xie DH; Yang XM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice.
    Fougerat A; Pan X; Smutova V; Heveker N; Cairo CW; Issad T; Larrivée B; Medin JA; Pshezhetsky AV
    Mol Metab; 2018 Jun; 12():76-88. PubMed ID: 29735266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
    Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
    FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability.
    Maurice P; Baud S; Bocharova OV; Bocharov EV; Kuznetsov AS; Kawecki C; Bocquet O; Romier B; Gorisse L; Ghirardi M; Duca L; Blaise S; Martiny L; Dauchez M; Efremov RG; Debelle L
    Sci Rep; 2016 Dec; 6():38363. PubMed ID: 27917893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1.
    Seyrantepe V; Hinek A; Peng J; Fedjaev M; Ernest S; Kadota Y; Canuel M; Itoh K; Morales CR; Lavoie J; Tremblay J; Pshezhetsky AV
    Circulation; 2008 Apr; 117(15):1973-81. PubMed ID: 18391110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term, high dose enzyme replacement therapy in sialidosis mice.
    Wang D; Bonten EJ; Yogalingam G; Mann L; d'Azzo A
    Mol Genet Metab; 2005 Jul; 85(3):181-9. PubMed ID: 15979029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.